APA (7th ed.) Citation

Chetwood, J., Redmond, D., Kermeen, M., Kariyawasam, V., Thin, L., Lightowler, D., . . . Walker, T. (2026). Randomised controlled trial of continued intravenous versus switching to subcutaneous infliximab in inflammatory bowel disease: The Subcutaneous Infliximab Switch Study (SISS). Journal of Crohn's & Colitis, 20, i2630.

Chicago Style (17th ed.) Citation

Chetwood, J., et al. "Randomised Controlled Trial of Continued Intravenous Versus Switching to Subcutaneous Infliximab in Inflammatory Bowel Disease: The Subcutaneous Infliximab Switch Study (SISS)." Journal of Crohn's & Colitis 20 (2026): i2630.

MLA (9th ed.) Citation

Chetwood, J., et al. "Randomised Controlled Trial of Continued Intravenous Versus Switching to Subcutaneous Infliximab in Inflammatory Bowel Disease: The Subcutaneous Infliximab Switch Study (SISS)." Journal of Crohn's & Colitis, vol. 20, 2026, p. i2630.